Funding Sources
Adult IA Adult Inflammatory Arthritis Guideline
Since inception in 2019, funding to support the development of the Adult Inflammatory Arthritis living guideline has been provided by:
ANZMUSC Clinical Trials Network
Core operational funding for guideline development and maintenance
NHMRC ANZMUSC Centre of Research Excellence
Continued funding through the second ANZMUSC CRE grant
NHMRC ANZMUSC Centre of Research Excellence
Initial CRE funding supporting guideline establishment
Victorian Government via ALEC
Australian Living Evidence Consortium funding
Cochrane Musculoskeletal
NHMRC Cochrane editorial base funding
Australian Department of Health VIP Program
Value in Prescribing bDMARDs Program Grant, awarded to the Targeted Therapies Alliance led by NPS MedicineWise
JIA Juvenile Idiopathic Arthritis Guideline
Since inception in 2020, funding to support the development of the JIA living guideline has been provided by:
Arthritis Australia Health Professional Education and Training Grant
GO ID: GO2794
Medical Research Future Fund (MRFF)
Chronic Musculoskeletal Conditions in Children and Adolescents Grant
NHMRC ANZMUSC Centre of Research Excellence
Initial CRE funding supporting guideline establishment
NHMRC ANZMUSC Centre of Research Excellence
Continued funding through the second ANZMUSC CRE grant
NHMRC Approval
Both guidelines have been approved by the National Health and Medical Research Council (NHMRC) under Section 14A of the National Health and Medical Research Council Act 1992.
Adult IA Adult Inflammatory Arthritis Guideline
JIA Juvenile Idiopathic Arthritis Guideline
In approving the guideline recommendations, NHMRC considers that they meet the NHMRC standard for clinical practice guidelines. Each approval is valid for a period of five years.
NHMRC is satisfied that the guideline recommendations are systematically derived, based on the identification and synthesis of the best available scientific evidence, and developed for health professionals practising in an Australian health care setting.
This publication reflects the views of the authors and not necessarily the views of the Australian Government.
How to Cite These Guidelines
Copyright
This work is copyright. You may download, display, print and reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction.
Apart from rights to use as permitted by the Copyright Act 1968 or allowed by this copyright notice, all other rights are reserved and you are not allowed to reproduce the whole or any part of this work in any way (electronic or otherwise) without first being given the specific written permission from ANZMUSC.
Requests and inquiries concerning reproduction and rights should be sent to vanessa.glennon@monash.edu.
Disclaimer
These clinical guidelines have been informed by the highest quality evidence available at the time of compilation. Accordingly, the parties involved in the development of these guidelines shall have no liability to any users of the information contained in this publication for any loss or damage, cost or expense incurred or arising from reliance on the information contained in this publication.